John Brian Savage, MS OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 111 School St, Romney, WV 26757 Phone: 304-822-3258 |
Raymond Felimon Flancia Recio Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 25072 Northwestern Pike, Romney, WV 26757 Phone: 304-822-2177 |
Catherine Haines Savage, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 301 E Main St, Romney, WV 26757 Phone: 304-822-4800 |
Justin Umstot Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 25072 Northwestern Pike, Romney, WV 26757 Phone: 304-822-2177 |
Bethany M Bergen Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 25072 Northwestern Pike, Romney, WV 26757 Phone: 304-822-2177 |
News Archive
The largest study ever of breast cancer in Latin American women is being launched this year in a unique multi-country, public/private partnership with $1 million in additional funding from the world's largest breast cancer organization, Susan G. Komen for the CureĀ®.
Transcend Services, Inc., a leading provider of clinical documentation solutions to the U.S. healthcare market, today announced its unaudited financial results for the second quarter ended June 30, 2011.
Clavis Pharma ASA, the clinical stage oncology focused pharmaceutical company, and Clovis Oncology, Inc., the newly formed oncology company led by former Pharmion Corporation executives, announced today an agreement for the further development and commercialisation of the Clavis Pharma drug candidate, CP-4126, currently in Phase II development in pancreatic cancer.
The rare disorder, called myotubular myopathy, or MTM, affects only males. It causes fatal muscle wasting. Both dogs and boys with the disease typically succumb in early life due to breathing difficulties.
Magellan Health Services, Inc. today reported net revenue of $728.1 million, net income of $25.5 million or $0.73 per diluted common share, and segment profit, representing income from continuing operations before stock compensation expense, depreciation and amortization, interest expense, interest income, gain on sale of assets, special charges or benefits, and income taxes, of $61.4 million for the quarter ended March 31, 2010.
› Verified 8 days ago